The mechanism of action of clozapine. [PDF]
Morrison PD, Jauhar S, Young AH.
europepmc +1 more source
Acetylcholine in the hippocampus: problems and achievements. [PDF]
Dobryakova YV+3 more
europepmc +1 more source
Cholinergic system in schizophrenia: A systematic review and meta-analysis. [PDF]
Saint-Georges Z+7 more
europepmc +1 more source
Evidence for M2 Muscarinic Receptor Antagonist Delay of Myopia Development Through Activation of Kir3.4 Channel in the Retina of Guinea Pigs. [PDF]
Zhou H+8 more
europepmc +1 more source
Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor. [PDF]
Chen K, Park E, Abd-Elrahman KS.
europepmc +1 more source
From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]
Meyer JM+4 more
europepmc +1 more source
Research progress in myocardial function and diseases related to muscarinic acetylcholine receptor (Review). [PDF]
Shen C, Zuo Q, Shao Z, Lin Y, Chen S.
europepmc +1 more source
Acetylcholine muscarinic M2 receptor maintains human Schwann-like adipose-derived phenotype in the absence of differentiating medium. [PDF]
Piovesana R, Faroni A, Tata AM, Reid AJ.
europepmc +1 more source
Discovery of Pre-Clinical Candidate <b>VU6008055</b>/<b>AF98943</b>: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy. [PDF]
Engers JL+26 more
europepmc +1 more source
Long-term muscarinic inhibition increases intrinsic excitability through the upregulation of A-type potassium currents in cortical neurons. [PDF]
Riquelme D+4 more
europepmc +1 more source